Literature DB >> 22841510

Immune quiescence and hepatitis B virus: tolerance has its limits.

Victoria M Velazquez1, Arash Grakoui2.   

Abstract

Mesh：

Year:  2012        PMID： 22841510     DOI： 10.1053/j.gastro.2012.07.089

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  4 in total

1.  Veritable antiviral capacity of natural killer cells in chronic HBV infection: an argument for an earlier anti-virus treatment.

Authors:  Xiaoyan Li; Liang Zhou; Lin Gu; Yurong Gu; Lubiao Chen; Yifan Lian; Yuehua Huang
Journal:  J Transl Med       Date:  2017-10-31       Impact factor: 5.531

Review 2.  CTLA‑4 interferes with the HBV‑specific T cell immune response (Review).

Authors:  Hui Cao; Ruiwen Zhang; Wei Zhang
Journal:  Int J Mol Med       Date:  2018-05-17       Impact factor: 4.101

3.  Quantitative HBsAg versus HBV DNA in Predicting Significant Hepatitis Activity of HBeAg-Positive Chronic HBV Infection.

Authors:  Zhanqing Zhang; Wei Lu; Dong Zeng; Dan Huang; Weijia Lin; Li Yan; Yanling Feng
Journal:  J Clin Med       Date:  2021-11-29       Impact factor: 4.241

4.  A Practical Model Evaluating Antiviral Cytokines by Natural Killer Cells in Treatment Naïve Patients with Chronic Hepatitis B Virus Infection.

Authors:  Xiaoyan Li; Yurong Gu; Xiaobo Guo; Lin Gu; Liang Zhou; Xiaojuan Wu; Xueqin Wang; Zania Stamataki; Yuehua Huang
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.